ProQR Therapeutics (PRQR) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to -$34465.6.
- ProQR Therapeutics' EPS (Weighted Average and Diluted) rose 657.52% to -$34465.6 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34465.6, marking a year-over-year increase of 657.52%. This contributed to the annual value of -$0.35 for FY2024, which is 851.9% up from last year.
- Per ProQR Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$34465.6 for Q3 2025, which was up 657.52% from -$61242.9 recorded in Q2 2025.
- In the past 5 years, ProQR Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of -$0.06 in Q4 2023 and a low of -$104500.0 during Q1 2025
- Over the past 5 years, ProQR Therapeutics' median EPS (Weighted Average and Diluted) value was -$34465.6 (recorded in 2025), while the average stood at -$39358.4.
- Per our database at Business Quant, ProQR Therapeutics' EPS (Weighted Average and Diluted) surged by 9999.9% in 2022 and then tumbled by 19574.93% in 2025.
- Quarter analysis of 5 years shows ProQR Therapeutics' EPS (Weighted Average and Diluted) stood at -$18980.2 in 2021, then skyrocketed by 100.0% to -$0.19 in 2022, then soared by 67.17% to -$0.06 in 2023, then crashed by 75.47% to -$0.11 in 2024, then plummeted by 32236151.02% to -$34465.6 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$34465.6 for Q3 2025, versus -$61242.9 for Q2 2025 and -$104500.0 for Q1 2025.